Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like AI and predictive medicine: Recent advances March 4, 2024 CMS introduces new payment model to improve kidney transplant outcomes December 2, 2024 Family physicians in rural hospitals and their impact on cesarean delivery rates September 24, 2024